Transurethral resection of prostate: A comparison of standard monopolar versus bipolar saline resection

Publication date: Available online 31 August 2018Source: African Journal of UrologyAuthor(s): A.I. Ebeid, A. Kotb, M.R. Rehan, G.I. SelmyAbstractObjectivesTo evaluate the efficacy to evaluate the efficacy and safety of bipolar transurethral resection in saline (TURIS) versus the conventional transurethral resection of the prostate (M-TURP) of benign prostatic hyperplasia (BPH) management.Patients and methodsIn a prospective randomized study, we likened the safety and efficacy of bipolar transurethral resection in saline (Group I, TURIS, n = 50 patients) using 0.9% saline versus standard monopolar transurethral resection (Group II, M-TURP, n = 50 patients) using 1.5% glycine as an irrigating fluid. Pre, perioperative and postoperative hemoglobin and hematocrit values were compared. Oxygen saturation and hemodynamic signs monitored throughout the operation. The operation was done under regional anesthesia. Serum electrolytes, osmolarity and packed cell volume Parameters (Hemoglobin and Hematocrit), estimated as a safety profile, while International Prostate Symptom Score (IPSS) and Q-max (maximum flow rate in mL/s) value estimated as an efficacy data.ResultsProstate size measured by transrectal ultrasound, was 60 ± 20 cc. The weight of resected tissue was 30.6 ± 10.8 g in the monopolar group and 40.66 ± 12.1 g (Group I, TURIS). Time of the operation, with a Mean 56.76 ± 14.51 min (glycine) against 55.1 ± 13....
Source: African Journal of Urology - Category: Urology & Nephrology Source Type: research

Related Links:

This study compared the surgical outcomes of the 120-W Thulium laser (Vela™ XL) enucleation of the prostate and bipolar transurethral resection of the prostate (TURP) in terms of efficacy, safety, and improvements of quality of life (QoL) in patients with benign prostate hyperplasia (BPH). Records were obtained from January 2014 to September 2018 for selected patients with symptomatic BPH who underwent 120-W Thulium laser (Vela™XL) prostate enucleation and bipolar TURP in our institution. All the patients selected met the surgical criteria for TURP and had received medical treatment for at least 3 months. Patie...
Source: Aging - Category: Biomedical Science Authors: Tags: Aging (Albany NY) Source Type: research
CONCLUSIONS: Although recognized and referenced as the BPH gold standard for the treatment of prostates over 80 cc, Canadian urology trainees' annual OSP exposure remains extremely limited. Considering the degree of importance given (category A) to the direct observation (of a minimum of five) of this intervention during residency training in the new Royal College's practice guidelines, it may be unrealistic to reach these national standards considering the annual case OSP volumes in Canadian academic urology faculties. PMID: 31977302 [PubMed - as supplied by publisher]
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Tags: Can Urol Assoc J Source Type: research
AbstractTo evaluate the clinical efficacy and safety of diode laser enucleation of the prostate (DiLEP) versus bipolar plasma kinetic enucleation of the prostate (PKEP) in the management of benign prostatic hyperplasia (BPH). A systematic literature search was undertaken using PubMed, Embase, Web of Science, Cochrane Library, and CKNI databases to identify eligible studies published before April 2019. The quality of evidence and methodology was assessed. Primary outcomes were clinical and demographic characteristics and postoperative efficacy including maximum flow rate (Qmax), postvoid residual (PVR), quality of life (QoL...
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research
This study adopted a multicenter, prospective, and real world design. BPH patients undergoing TUPKP were divided into two groups according to whether they adopted Hemocoagulase Bothrops Atrox (group B) or not (group A) during perioperative period. The electronic clinical data on every included subject, including the international prostate symptom score (IPSS) and the quality of life scale (QoL), maximum urinary flow rate (Qmax), complete blood count, coagulation screening test and adverse events, were measured and compared between the two groups.Results: Finally, 695 patients, 443 in group A and 252 in group B were include...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
In this study, we compared results of bipolar TURP using the resection loop versus vaporization button for treatment of benign prostatic hyperplasia (BPH) to determine the relative safety profile.Patients and methodsBetween January 2013 and March 2014, 89 patients with BPH were randomized to surgical intervention either by Olympus (Gyrus) Bipolar loop TURP or Olympus (Gyrus) Bipolar button vaporization. Inclusion criteria were; BPH with Q-max    18 and prostate volume >  40 g. All patients were evaluated preoperatively and at 1, 3 and 9 months. Evaluation included IPSS, uroflowmetry, pro...
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
Conditions:   Prostatic Hyperplasia;   Lower Urinary Tract Symptoms;   Transurethral Resection of Prostate Intervention:   Device: Transurethral Resection of the Prostate (TURP) Sponsor:   Hospital Universitario de Fuenlabrada Active, not recruiting
Source: - Category: Research Source Type: clinical trials
TRW Abstract The spectrum of surgical procedures for the minimally invasive treatment of benign prostatic hyperplasia (BPH) has significantly increased over the last two decades. The simple suprapubic prostatectomy (subtotal prostatectomy, SP) has largely lost relevance in current practice. On the other hand, transurethral resection of the prostate (TURP) has been further standardized and potentially made safer by the introduction of the bipolar technique and low-pressure systems.Transurethral (endoscopic) enucleation techniques (endoscopic enucleation of the prostate, EEP) are increasingly competing with the curr...
Source: Der Urologe. Ausg. A - Category: Urology & Nephrology Authors: Tags: Urologe A Source Type: research
Journal of Endourology,Volume 33, Issue 3, Page 218-218, March 2019.
Source: Journal of Endourology - Category: Urology & Nephrology Authors: Source Type: research
CONCLUSIONS: Choice of surgical treatment of BPH should be individualized and based on prostate size, comorbidities and surgical experience. PMID: 30847529 [PubMed - as supplied by publisher]
Source: Der Urologe. Ausg. A - Category: Urology & Nephrology Authors: Tags: Urologe A Source Type: research
More News: African Health | Anesthesia | Anesthesiology | Benign Prostatic Hyperplasia | Bipolar | Mania | Sodium | Statistics | Study | Ultrasound | Urology & Nephrology